stockrowAxoGen, Inc.
AXGN Healthcare Medical Devices
AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.
- Revenue
- +26.2%
- EPS
- +178.3%
- Free cash flow
- +995.0%
- Total debt
- −73.1%
Quarter to September 2026, against a year earlier
Follow AXGN
Alert me
AxoGen, Inc. (AXGN) Free cash flow
AxoGen, Inc.'s free cash flow for fiscal 2025 was −$4.8M, compared with $11.0K in fiscal 2024. Over the twelve months to 30 September 2026 it was $20.0M. Over the past ten years it has ranged from −$41.8M (fiscal 2021) to $11.0K (fiscal 2024); the current reading is higher than 91% of that period. AxoGen, Inc. ranks 36th of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$4.8M | — |
| FY2024 | $11.0K | — |
| FY2023 | −$20.6M | — |
| FY2022 | −$37.3M | — |
| FY2021 | −$41.8M | — |
| FY2020 | −$32.2M | — |
| FY2019 | −$25.1M | — |
| FY2018 | −$24.5M | — |
| FY2017 | −$10.5M | — |
| FY2016 | −$12.4M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $14.9M | 171.80% |
| Jun 2026 | $5.5M | — |
| Mar 2026 | −$1.4M | — |
| Dec 2025 | $1.1M | (20.47%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | $97.9M |
| ITGR Integer Holdings Corporation compare | $81.8M |
| UFPT UFP Technologies, Inc. compare | $61.5M |
| NEOG Neogen Corporation compare | $49.9M |
| TMDX TransMedics Group, Inc. compare | $44.7M |
| AXGN AxoGen, Inc. | $20.0M |
| IRTC iRhythm Holdings, Inc. compare | $7.4M |
| ESTA Establishment Labs Holdings Inc. compare | −$41.6M |
| ALMR Alamar Biosciences, Inc. compare | −$110.1M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on AXGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement